RNA Polymerase Beta Subunit (rpoB)

rpoB is the universally conserved bacterial housekeeping gene that encodes the β subunit (~150 kDa; 1,342 amino acids and 4,029 bp in Escherichia coli) of prokaryotic DNA-dependent RNA polymerase (RNAP). Within the five-subunit bacterial core enzyme (α2ββ′ω, total molecular mass ~400 kDa) and the σ-factor-bound holoenzyme (α2ββ′ωσ), the β (RpoB) and β′ (RpoC) polypeptides fold together like the two opposing claws of a crab pincer to form the central positively charged DNA-binding channel, the catalytic active-site cleft, and the nascent RNA exit tunnel required for all cellular transcription.

In clinical medicine and evolutionary genomics, rpoB occupies a dual position of importance. First, a conserved hydrophobic pocket along the wall of the RpoB RNA/DNA hybrid exit channel is the direct molecular target of the bactericidal rifamycin class of antibiotics (rifampicin, rifabutin, rifapentine, and rifaximin); point mutation within the 81-bp Rifampicin Resistance-Determining Region (RRDR) of rpoB drives >95% of rifampicin resistance in Mycobacterium tuberculosis and forms the molecular basis of the global Xpert MTB/RIF diagnostic assay. Second, because rpoB exists strictly as a single-copy chromosomal gene across Bacteria and evolves at an optimal synonymous rate under strong nonsynonymous purifying selection, rpoB sequencing resolves closely related bacterial sister species where multi-copy 16S ribosomal RNA (rrsA–rrsH) fails due to intragenomic paralog divergence and barcoding-gap collapse.

The β/β′ Active-Site Cleft and Two-Metal-Ion Catalysis

High-resolution X-ray crystal structures of Thermus aquaticus, Thermus thermophilus, and Escherichia coli RNA polymerase solved by Seth Darst, Roger Kornberg, Dmitry Vassylyev, and Richard Ebright demonstrate that the bacterial RNAP core shares deep evolutionary homology with archaeal RNAP and eukaryote RNA Polymerase II (RPB2 is the eukaryotic orthologue of bacterial RpoB). Inside the crab-claw architecture, the β′ (RpoC) subunit forms the upper pincer (clamp domain) and carries the invariant NADFDGD motif (Asp460, Asp462, Asp464), which chelates the primary catalytic magnesium ion (Mg²⁺ I).

The β (RpoB) subunit forms the lower pincer (lobe, protrusion, and flap domains) and contributes essential basic and acidic residues (Asp814 and Glu813 in E. coli) that help coordinate the nucleotide-bound second magnesium ion (Mg²⁺ II), bind the incoming ribonucleoside triphosphate (NTP) substrate in the i+1 site, stabilize the 8–9 base-pair RNA:DNA hybrid inside the transcription bubble, and separate the nascent messenger RNA transcript from the template DNA strand at the upstream rudder, lid, and flap-tip elements as the RNA enters the exit channel.

Steric-Occlusion Mechanism of Rifamycin Antibiotics

Unlike DNA gyrase poisons that shear DNA or β-lactam antibiotics that lyse the cell wall, rifampicin (and its semisynthetic derivatives rifabutin, rifapentine, and the non-absorbable gut antibiotic rifaximin) inhibits bacterial transcription via a direct steric-occlusion mechanism discovered structurally by Seth Darst and colleagues in 2001. Rifampicin binds with sub-nanomolar to nanomolar affinity (K_d ≈ 10⁻⁹ M) to a deep pocket on the RpoB subunit situated inside the main channel, approximately 12 Å away from the catalytic Mg²⁺ active center along the path of the growing RNA:DNA hybrid.

Because rifampicin does not block the i and i+1 catalytic nucleotide-binding sites, an rifampicin-bound RNA polymerase holoenzyme can still bind a promoter, melt the transcription bubble, and catalyze the synthesis of the first phosphodiester bond to form a dinucleotide (2-nt RNA) or trinucleotide (3-nt RNA). However, as soon as the nascent transcript reaches 2 to 3 nucleotides in length, its 5′-phosphate/triphosphate group collides sterically with the rigid naphthohydroquinone core and ansa-bridge of the bound rifampicin molecule. Blocked from translocating into the RNA exit channel, the 2–3 nt abortive RNA transcript dissociates from the complex, trapping the polymerase in futile abortive initiation and halting all bacterial gene expression.

The Rifampicin Resistance-Determining Region (RRDR)

More than 95% of all clinical rifampicin-resistant isolates of Mycobacterium tuberculosis, Staphylococcus aureus, Neisseria meningitidis, and Escherichia coli harbor missense mutations, short in-frame deletions, or insertions within an evolutionarily conserved 81-base-pair (27-codon) core region of rpoB termed the Rifampicin Resistance-Determining Region (RRDR / Cluster I). Historically, clinical mycobacteriology literature numbered M. tuberculosis rpoB codons using the E. coli reference alignment (codons 507 to 533), which corresponds to codons 426 to 452 in actual M. tuberculosis H37Rv numbering.

Crystal structures of the RpoB–rifampicin complex show that the four essential hydroxyl groups on the rifampicin ansa-naphthohydroquinone ring (O1, O2, O8, O9, and O10) form a tight hydrogen-bonding cage with side chains inside the RRDR—specifically Gln513, Asp516, His526, and Ser531 (E. coli numbering). Replacing Ser531 with Leu (S531L / Mtb S450L), His526 with Tyr or Asp (H526Y / Mtb H445Y), or Asp516 with Val (D516V / Mtb D435V) introduces steric bulk or eliminates a key hydrogen bond, increasing the dissociation constant (K_d) of rifampicin by 1,000-fold to >10,000-fold. The World Health Organization-endorsed Cepheid Xpert MTB/RIF and Xpert MTB/RIF Ultra cartridge assays exploit this 81-bp window using five overlapping molecular-beacon probes (Probes A–E or sloppy molecular beacons with high-resolution melt analysis): any mutation inside the 81-bp RRDR delays or abolishes probe hybridization, diagnosing both M. tuberculosis infection and multidrug-resistant tuberculosis (MDR-TB surrogate) directly from sputum in under two hours.

Fitness Costs and Inter-Subunit Epistatic Compensation in rpoA and rpoC

Because the 81-bp RRDR lines the active transcription channel, most primary rifampicin-resistance mutations (His526Asp, Asp516Val, Gln513Pro, and even Ser531Leu to a milder extent) alter transcription elongation kinetics, termination efficiency, and stringent-response (ppGpp) regulation—imposing a measurable competitive fitness cost in antibiotic-free environments.

Longitudinal whole-genome sequencing of clinical MDR-TB transmission chains by Sebastien Gagneux, Dan Andersson, and colleagues demonstrated that rpoB RRDR mutants evolve secondary compensatory mutations driven by inter-subunit epistasis and coevolution. These compensatory substitutions map predominantly to the ψ-barrel interface domain of rpoC (β′ subunit, codons 432–516, such as Val483Gly/Ala and Ile491Thr) and the C-terminal interface of rpoA (α subunit, codons 180–200). By restoring the structural rigidity and allosteric coupling across the β–β′ cleft, double mutants (rpoB S450L + rpoC V483G) recover wild-type transcriptional elongation rates (~45–55 nt/s) and transmit through human populations with zero evolutionary fitness penalty.

Overcoming the Multi-Copy 16S rRNA Enteric Barcoding Collapse

In prokaryotic phylogenetics, clinical microbiology, and metagenomics, the 16S rRNA gene (~1,542 bp) serves as the classical universal anchor from Phylum down to Genus (stem Shannon entropy H_stem ≈ 0.49 bits; hypervariable V1–V9 loop entropy H_loop ≈ 1.68 bits). However, 16S rRNA suffers from two severe diagnostic failure boundaries at the species and strain levels:

1. Intragenomic Paralog Heterogeneity: Rapidly growing bacteria carry multiple ribosomal operon copies per chromosome (7 copies rrnA–rrnH in Escherichia coli and Salmonella enterica; up to 15 copies in Bacillus and Clostridium). Sequence polymorphisms among the 7 rrs copies within a single E. coli genome reach a Kimura 2-parameter divergence of d_K2P = 0.0091, which splits a single clonal isolate into 4 to 6 distinct 100%-identity Amplicon Sequence Variants (ASVs, haplotype diversity H_d ≈ 0.895).
2. Negative Inter-Species Barcoding Gap: Because the inter-species 16S rRNA divergence between Escherichia coli (NC_000913.3) and its sister species Salmonella enterica (NC_003197.2) is only d_K2P = 0.0078, the intragenomic noise (0.0091) exceeds the inter-species signal (0.0078), producing a collapsed negative barcoding gap (−0.0013) that renders short-read 16S amplicons incapable of separating enteric sister species (E. coli / Shigella / Salmonella, Klebsiella / Raoultella, or Enterobacter cloacae complex).

Switching to the single-copy rpoB locus (4,029 bp; or its hypervariable diagnostic region spanning positions 1,300–2,600 bp flanked by conserved primer sites) eliminates paralog splitting (N = 1 copy per genome) and increases inter-species divergence between E. coli and S. enterica nearly 9-fold to d_K2P = 0.0684 (~6.8% nucleotide divergence, driven by synonymous substitutions at third-codons positions where ω = dN/dS ≈ 0.015). This restores a positive species barcoding gap (>15× intra-species diversity) and provides 100% bootstrap resolution across Enterobacterales, Mycobacterium (M. abscessus subspecies complex), Corynebacterium, Staphylococcus, and Acinetobacter.

How does rifampicin stop bacterial transcription without blocking the catalytic active site of RNA polymerase?

Rifampicin binds to a pocket on the RpoB (β) subunit located inside the RNA/DNA hybrid channel ~12 Å downstream from the catalytic Mg²⁺ ions. Because the catalytic center itself remains unobstructed, RNA polymerase can still bind the promoter and link the first two or three ribonucleotides together. However, once the nascent RNA reaches 2 to 3 nucleotides in length, its 5′ end physically collides with the bound rifampicin molecule, blocking translocation into the RNA exit channel and forcing abortive release of the short transcript.

Why do more than 95% of clinical rifampicin-resistant M. tuberculosis strains carry mutations in a single 81-bp region of rpoB?

Because RpoB forms the essential catalytic core of RNA polymerase, frame-shifts or large deletions in rpoB are lethal to the bacterium. To survive rifampicin exposure, the bacterium must alter one of the specific amino acid side chains (Ser531/Ser450, His526/His445, or Asp516/Asp435) inside the 81-bp Rifampicin Resistance-Determining Region (RRDR) so that rifampicin can no longer hydrogen-bond to the pocket, while keeping the surrounding polypeptide fold intact so normal mRNA transcription can continue.

Why does rpoB resolve Escherichia coli and Salmonella enterica when 16S rRNA sequencing fails?

Escherichia coli carries seven copies of the 16S rRNA gene (rrsA–rrsH) whose internal differences (0.91% divergence) are actually larger than the average 16S rRNA difference between E. coli and Salmonella enterica (0.78% divergence), causing taxonomic collapse. In contrast, rpoB is present in only a single copy per chromosome and accumulates neutral synonymous changes at third-codon positions, separating E. coli and S. enterica by ~6.8% nucleotide divergence (d_K2P = 0.0684) with zero paralog ambiguity.

1. Campbell, E. A., Korzheva, N., Mustaev, A., Murakami, K., Nair, S., Goldfarb, A., & Darst, S. A. (2001). "Structural mechanism for rifampicin inhibition of bacterial RNA polymerase." Cell, 104(6), 901–912. https://doi.org/10.1016/S0092-8674(01)00286-000286-0)
2. Telenti, A., Imboden, P., Marchesi, F., Lowrie, D., Cole, S., Colston, M. J., Matter, L., Schopfer, K., & Bodmer, T. (1993). "Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis." The Lancet, 341(8846), 647–650. https://doi.org/10.1016/0140-6736(93)90417-F90417-F)
3. Comas, I., Borrell, S., Roetzer, A., Rose, G., Malla, B., Kato-Maeda, M., Galagan, J., Niemann, S., & Gagneux, S. (2012). "Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes." Nature Genetics, 44(1), 106–110. https://doi.org/10.1038/ng.1038
4. Mollet, C., Drancourt, M., & Raoult, D. (1997). "rpoB sequence analysis as a novel basis for bacterial identification." Molecular Microbiology, 26(5), 1005–1011. https://doi.org/10.1046/j.1365-2958.1997.6382009.x